Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-FR Version v6-EN
Language French English
Date Updated 2023-10-02 2023-10-02
Drug Identification Number 02401274 02401274
Brand name AURO-MONTELUKAST AURO-MONTELUKAST
Common or Proper name MONTELUKAST MONTELUKAST
Company Name AURO PHARMA INC AURO PHARMA INC
Ingredients MONTELUKAST MONTELUKAST
Strength(s) 10MG 10MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 3X10 Blst 3X10 Blst
ATC code R03DC R03DC
ATC description OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2023-07-21 2023-07-21
Estimated end date 2023-09-30 2023-09-30
Actual end date 2023-09-30 2023-09-30
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments
Health Canada comments